Sputnik 5 Vaccine
- All
- News
- Videos
- Web Stories
-
To Stop 3rd Wave, India Needs 8.6 Million Jabs A Day. Actual Rate Is...
Having seen off a deadly second wave of coronavirus infections, India is now praying that a third wave doesn't emerge to rampage through the country.
-
5 Units Set Up, Gurgaon May Start Sputnik V Rollout From Next Week
Residents of Gurgaon may soon be able to get jabs of Russian coronavirus vaccine Sputnik V.
-
Highlights Of #VaccinateIndia Telethon: An Initiative To Encourage Vaccination Against COVID-19
New Delhi Television Limited (NDTV) in partnership with Google has initiated the #VaccinateIndia campaign. The aim of the campaign is to empower people with the right information about vaccines, their safety and efficacy.
-
India Becomes Second Country To Record 20 Crore Vaccinations: Centre
India has become the second country after the US to have crossed 20 crore cumulative COVID-19 vaccination coverage, the Union health ministry said on Wednesday.
-
Panacea Biotec Soars 5% On Starting Sputnik V Manufacturing in India
"The first batch produced at the company's facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer," Panacea Biotech said
-
Dr Reddy's Labs Slides Despite Government Go-Ahead For Sputnik Vaccine
The company's shares had opened at a high of Rs 5,200 per share. They had closed at Rs 4,989 on Monday.
-
Sputnik V Approved By Experts, Third Vaccine For India
Russia's Covid vaccine Sputnik V has been recommended for use in India by a committee of experts as the country battles a record spike in infections.
-
Coronavirus Highlights: Russia's Sputnik 5 Vaccine Recommended For Use In India By Experts' Panel
Russia's Covid vaccine Sputnik-V has been cleared for emergency use approval in India by a committee of experts in the middle of a record spike in virus cases in the country.
-
On Request For Sputnik 5 Vaccine Approval, Panel Seeks More Data: Sources
The Subject Expert Committee (SEC) of the Indian drug regulator has asked pharma giant Dr Reddy's Laboratories, the Indian manufacturer of Sputnik V, the Russia-developed coronavirus vaccine, for more data regarding its application for emergency use approval for the vaccine, sources said.
-
Sputnik 5, Efficacy 91.6%, For India? Meeting Today To Review
The Subject Expert Committee (SEC) of the Indian drug regulator will meet today to take up an application by pharma giant Dr Reddy's Laboratories seeking emergency approval for Sputnik V, the Russia-developed coronavirus vaccine. The vaccine has an efficacy of 91.6 per cent.
-
Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V
Dr Reddy's will present the safety profile of phase two study and interim data of phase three study which is expected to completed by February 21
-
Sputnik V Can Be "Highly Effective" Against New Covid Strain: Co-Developer
Sputnik V, the world's first COVID-19 vaccine, will be "highly effective" against the new strain of coronavirus found in Europe, said Kirill Dmitriev, Chief Executive Officer (CEO) of Russian Direct Investment Fund, the company which co-developed the vaccine.
-
To Stop 3rd Wave, India Needs 8.6 Million Jabs A Day. Actual Rate Is...
Having seen off a deadly second wave of coronavirus infections, India is now praying that a third wave doesn't emerge to rampage through the country.
-
5 Units Set Up, Gurgaon May Start Sputnik V Rollout From Next Week
Residents of Gurgaon may soon be able to get jabs of Russian coronavirus vaccine Sputnik V.
-
Highlights Of #VaccinateIndia Telethon: An Initiative To Encourage Vaccination Against COVID-19
New Delhi Television Limited (NDTV) in partnership with Google has initiated the #VaccinateIndia campaign. The aim of the campaign is to empower people with the right information about vaccines, their safety and efficacy.
-
India Becomes Second Country To Record 20 Crore Vaccinations: Centre
India has become the second country after the US to have crossed 20 crore cumulative COVID-19 vaccination coverage, the Union health ministry said on Wednesday.
-
Panacea Biotec Soars 5% On Starting Sputnik V Manufacturing in India
"The first batch produced at the company's facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer," Panacea Biotech said
-
Dr Reddy's Labs Slides Despite Government Go-Ahead For Sputnik Vaccine
The company's shares had opened at a high of Rs 5,200 per share. They had closed at Rs 4,989 on Monday.
-
Sputnik V Approved By Experts, Third Vaccine For India
Russia's Covid vaccine Sputnik V has been recommended for use in India by a committee of experts as the country battles a record spike in infections.
-
Coronavirus Highlights: Russia's Sputnik 5 Vaccine Recommended For Use In India By Experts' Panel
Russia's Covid vaccine Sputnik-V has been cleared for emergency use approval in India by a committee of experts in the middle of a record spike in virus cases in the country.
-
On Request For Sputnik 5 Vaccine Approval, Panel Seeks More Data: Sources
The Subject Expert Committee (SEC) of the Indian drug regulator has asked pharma giant Dr Reddy's Laboratories, the Indian manufacturer of Sputnik V, the Russia-developed coronavirus vaccine, for more data regarding its application for emergency use approval for the vaccine, sources said.
-
Sputnik 5, Efficacy 91.6%, For India? Meeting Today To Review
The Subject Expert Committee (SEC) of the Indian drug regulator will meet today to take up an application by pharma giant Dr Reddy's Laboratories seeking emergency approval for Sputnik V, the Russia-developed coronavirus vaccine. The vaccine has an efficacy of 91.6 per cent.
-
Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V
Dr Reddy's will present the safety profile of phase two study and interim data of phase three study which is expected to completed by February 21
-
Sputnik V Can Be "Highly Effective" Against New Covid Strain: Co-Developer
Sputnik V, the world's first COVID-19 vaccine, will be "highly effective" against the new strain of coronavirus found in Europe, said Kirill Dmitriev, Chief Executive Officer (CEO) of Russian Direct Investment Fund, the company which co-developed the vaccine.
